Authors:
Deghenghi, R
Papotti, M
Chigo, E
Muccioli, G
Locatelli, V
Citation: R. Deghenghi et al., Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland, ENDOCRINE, 14(1), 2001, pp. 29-33
Authors:
Torsello, A
Rossoni, G
Locatelli, V
Colonna, VD
Bernareggi, M
Francolini, M
Muller, EE
Berti, F
Citation: A. Torsello et al., Hexarelin, but not growth hormone, protects heart from damage induced in vitro by calcium deprivation replenishment, ENDOCRINE, 14(1), 2001, pp. 109-112
Authors:
Rigamonti, AE
Cavallera, G
Bonomo, S
Deghenghi, R
Locatelli, V
Cella, SG
Muller, EE
Citation: Ae. Rigamonti et al., Growth hormone (GH) rebound rise following somatostatin infusion withdrawal: studies in dogs with the use of GH-releasing hormone and a GH-releasing peptide, EUR J ENDOC, 145(5), 2001, pp. 635-644
Authors:
Rigamonti, AE
Cella, SG
Cavallera, GM
Deghenghi, R
Locatelli, V
Pitsikas, N
Muller, EE
Citation: Ae. Rigamonti et al., Contrasting effects of nitric oxide on food intake and GH secretion stimulated by a GH-releasing peptide, EUR J ENDOC, 144(2), 2001, pp. 155-162
Authors:
Muccioli, G
Papotti, M
Locatelli, V
Ghigo, E
Deghenghi, R
Citation: G. Muccioli et al., Binding of I-125-labeled ghrelin to membranes from human hypothalamus and pituitary gland, J ENDOC INV, 24(3), 2001, pp. RC7-RC9
Authors:
Roumi, M
Kwong, E
Deghenghi, R
Locatelli, V
Marleau, S
Du Souich, P
Beliveau, R
Ong, H
Citation: M. Roumi et al., Permeability of the peptidic GH secretagogues hexarelin and EP 51389, across rat jejunum, PEPTIDES, 22(7), 2001, pp. 1129-1138
Authors:
Pitsikas, N
Rigamonti, AE
Cella, SG
Locatelli, V
Sala, M
Muller, EE
Citation: N. Pitsikas et al., Effects of molsidomine on scopolamine-induced amnesia and hypermotility inthe rat, EUR J PHARM, 426(3), 2001, pp. 193-200
Authors:
Melis, MR
Succu, S
Spano, MS
Torsello, A
Locatelli, V
Muller, EE
Deghenghi, R
Argiolas, A
Citation: Mr. Melis et al., Penile erection induced by EP 80661 and other hexarelin peptide analogues:involvement of paraventricular nitric oxide, EUR J PHARM, 411(3), 2001, pp. 305-310
Authors:
Rossoni, G
Locatelli, V
Colonna, VD
Muller, EE
Berti, F
Citation: G. Rossoni et al., Hexarelin, a growth hormone secretagogue, protects the isolated rat heart from ventricular dysfunction produced by exposure to calcium-free medium, PHARMAC RES, 42(2), 2000, pp. 129-136
Authors:
Melis, MR
Spano, MS
Succu, S
Locatelli, V
Torsello, A
Muller, EE
Deghenghi, R
Argiolas, A
Citation: Mr. Melis et al., EP 60761-and EP 50885-induced penile erection: structure-activity studies and comparison with apomorphine, oxytocin and N-methyl-D-aspartic acid, INT J IMPOT, 12(5), 2000, pp. 255-262
Authors:
Torsello, A
Locatelli, V
Melis, MR
Succu, S
Spano, MS
Deghenghi, R
Muller, EE
Argiolas, A
Citation: A. Torsello et al., Differential orexigenic effects of hexarelin and its analogs in the rat hypothalamus: Indication for multiple growth hormone secretagogue receptor subtypes, NEUROENDOCR, 72(6), 2000, pp. 327-332
Authors:
Rossoni, G
Locatelli, V
Colonna, VD
Torsello, A
Schweiger, F
Boghen, M
Nilsson, M
Bernareggi, M
Muller, EE
Berti, F
Citation: G. Rossoni et al., Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aortic rings of the hypophysectomized rat, J CARDIO PH, 34(3), 1999, pp. 454-460
Authors:
Franciotta, D
Martino, G
Brambilla, E
Zardini, E
Locatelli, V
Bergami, A
Tinelli, C
Desina, G
Cosi, V
Citation: D. Franciotta et al., TE671 cell-based ELISA for anti-acetylcholine receptor antibody determination in myasthenia gravis, CLIN CHEM, 45(3), 1999, pp. 400-405